Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is the fifth
leading cause of cancer death worldwide and the third leading cause of all diseases …

Background & Aims Radiofrequency ablation (RFA) and ablative external beam
radiotherapy (ablative RT) are commonly used to treat small intrahepatic malignancies. We …

Objectives The purpose of this study was to evaluate the 10-year overall survival and local
tumor progression (LTP) of percutaneous radiofrequency ablation (RFA) for single nodular …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Hepatocellular carcinoma (HCC) accounts for the vast majority of primary liver cancer and
constitutes a major global health challenge. Tumor ablation with either radiofrequency …

BACKGROUND: A wide range of ablative and non-surgical therapies are available for
treating small hepatocellular carcinoma in patients with very early or early-stage disease …

Purpose Radiofrequency ablation is a curative treatment option for very early-stage or early-
stage hepatocellular carcinoma (HCC). However, percutaneous radiofrequency ablation …

Although hepatocellular carcinoma (HCC) is associated with a poor prognosis, management
of early-stage HCC is often successful with highly efficacious treatment modalities such as …